The trademark application was filed by AstraZeneca UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on June 18, 2020, and it was registered by office on September 28, 2020 without any oppositions.
It was designated 'Basic Application' for International Application 1550359 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
A transfer of the trademark registration was recorded on July 13, 2020.